The induction of organ system toxicity by the subchronic inhalation of diethylamine (109897) (DEA) vapors was studied in rats. Fischer- 344-rats of both sexes underwent inhalation exposure to DEA vapors at concentrations of 0, 25, or 250 parts per million (ppm) 6.5 hours per day, 5 days per week, for a period of 24 weeks. Male and female animals randomly selected from each exposure group were sacrificed after 30, 60, or 120 days of treatment. During the first 2 weeks of testing, rats exposed to DEA at a concentration of 250ppm did not gain weight; however, the rate of weight gain among these animals was greater than among controls thereafter, although the mean body weights of both sexes remained depressed throughout the experimental period. Sneezing, lacrimation, and reddening of the nose were also observed among animals undergoing exposure to DEA at the 250ppm concentration, with histopathological examinations revealing lesions of the nasal mucosa, primarily consisting of squamous metaplasia, suppurative rhinitis, and lymphoid hyperplasia. Blood urea nitrogen was elevated among both male and female rats undergoing exposure to DEA at a concentration of 250ppm for a period of 24 weeks. The authors conclude that DEA, inhaled at concentrations as high as 250ppm, does not induce cardiotoxicity in rats. It is recommended that further research be conducted for the purpose of investigating the time course, threshold, and incidence of nasal lesions among animals exposed to DEA.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.